Stockholders' Deficit - Schedule of Stock Warrant Activity (Details) - Warants [Member] - $ / shares |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
Sep. 30, 2025 |
Dec. 31, 2025 |
Jun. 30, 2026 |
|
| Schedule of Stock Warrant Activity [Line Items] | |||
| Number of Warrants Outstanding and Exercisable Beginning Balance | 3,150,000 | 1,710,000 | |
| Weighted Average Exercise Price Outstanding and Exercisable Beginning Balance | $ 0.001 | $ 0.001 | |
| Weighted Average Contractual Term Outstanding and exercisable Beginning Balance | 6 months 25 days | ||
| Number of Warrants Exercised | (1,440,000) | (1,710,000) | |
| Weighted Average Exercise Price Exercised | $ 0.001 | $ 0.001 | |
| Number of Warrants Issued | 900,000 | ||
| Weighted average exercise price issued | $ 1 | ||
| Number of Warrants Outstanding and Exercisable Ending Balance | 3,150,000 | 1,710,000 | |
| Weighted Average Exercise Price Outstanding and exercisable Ending Balance | $ 0.001 | $ 0.001 | |
| Weighted Average Contractual Term Outstanding and exercisable Ending Balance | 3 months 25 days | 4 years 10 months 24 days |
| X | ||||||||||
- Definition Number of warrants issued. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price issued. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|